Abstract
Lentiviral vectors have been used extensively as gene transfer tools for the central nervous system throughout the past decade since they transduce most cell types in the brain, resulting in high-level and long-term transgene expression. This review discusses some of the recent progress in this field, including preclinical gene therapy experiments in disease models, development of regulated vectors, and the application of siRNA's using lentiviral vectors. We also describe some of the features that make lentiviral vectors a likely candidate for human gene therapy in the brain.
| Original language | English |
|---|---|
| Pages (from-to) | 484-493 |
| Journal | Molecular Therapy |
| Volume | 13 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Subject classification (UKÄ)
- Medical Genetics and Genomics (including Gene Therapy)
Free keywords
- neurological disorders
- brain
- lentivirus
- gene therapy
- siRNA
- Tet system
Fingerprint
Dive into the research topics of 'Lentiviral Vectors for Use in the Central Nervous System.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver